IDS anticorps
-
- Antigène Voir toutes IDS Anticorps
- IDS (Iduronate 2-Sulfatase (IDS))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IDS est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Purification
- Protein A+G purification
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- iduronate 2-sulfatase
- Clone
- 2D2
- Isotype
- IgG1
- Top Product
- Discover our top product IDS Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- IDS (Iduronate 2-Sulfatase (IDS))
- Autre désignation
- Iduronate 2 sulfatase (IDS Produits)
- Synonymes
- anticorps mps2, anticorps sids, anticorps zgc:158245, anticorps MPS2, anticorps SIDS, anticorps AW214631, anticorps iduronate 2-sulfatase, anticorps IDS, anticorps CpipJ_CPIJ004938, anticorps ids, anticorps Ids
- Sujet
- Synonyms:IDS, iduronate 2 sulfatase, Idursulfase Background:Iduronate 2-sulfatase (IDS) is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations causing IDS deficiency in humans result in the lysosomal storage of these glycosaminoglycans and Hunter syndrome, an X chromosome-linked disease. IDS is synthesized as two precursor forms of 76 and 90 kDa that are converted, through a 62 kDa intermediate, to 55 and 45 kDa mature polypeptides due to an internal proteolytic cleavage (PMID: 10838181).
- Poids moléculaire
- 76 kDa, 55 kDa
- ID gène
- 3423
- UniProt
- P22304
- Pathways
- Glycosaminoglycan Metabolic Process
-